Saudi Pharmaceutical Industries & Medical Appliances (SAU:2070) Research & Development: ﷼59 Mil (TTM As of Mar. 2026)


SAU:2070 Saudi Pharmaceutical Industries & Medical Appliances Corp SAU:2070
69 GF Score
Price ﷼28.26
GF Value ﷼31.13
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Saudi Pharmaceutical Industries & Medical Appliances Research & Development?

Saudi Pharmaceutical Industries & Medical Appliances SAU:2070 +0.28% 69 Research & Development is ﷼59 Mil as of Mar. 2026. GuruFocus rates SAU:2070 with a GF Score™ of 69/100 and a GF Value™ of ﷼31.13 (Fairly Valued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Saudi Pharmaceutical Industries & Medical Appliances's Research & Development for the three months ended in Mar. 2026 was ﷼11 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ﷼59 Mil.

Saudi Pharmaceutical Industries & Medical Appliances  (SAU:2070) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Saudi Pharmaceutical Industries & Medical Appliances Research & Development Related Terms

Saudi Pharmaceutical Industries & Medical Appliances Research & Development Historical Data

* Premium members only.

The historical data trend for Saudi Pharmaceutical Industries & Medical Appliances's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Saudi Pharmaceutical Industries & Medical Appliances Research & Development Chart

Saudi Pharmaceutical Industries & Medical Appliances Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.12 42.65 41.80 76.39 60.48

Saudi Pharmaceutical Industries & Medical Appliances Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.87 15.07 13.76 18.79 11.13
SAU:2070
69GF Score
Saudi Pharmaceutical Industries & Medical Appliances Corp SAU:2070
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Saudi Pharmaceutical Industries & Medical Appliances Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ﷼59 Mil mean?
Saudi Pharmaceutical Industries & Medical Appliances (SAU:2070) has a Research & Development of ﷼59 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Saudi Pharmaceutical Industries & Medical Appliances and its competitors.
Is Saudi Pharmaceutical Industries & Medical Appliances' Research & Development too high?
Saudi Pharmaceutical Industries & Medical Appliances' current Research & Development is ﷼59 Mil. Overall, Saudi Pharmaceutical Industries & Medical Appliances has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Saudi Pharmaceutical Industries & Medical Appliances' Research & Development compare to ZTS and UTHR?
Saudi Pharmaceutical Industries & Medical Appliances' Research & Development of ﷼59 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Saudi Pharmaceutical Industries & Medical Appliances and its competitors. Saudi Pharmaceutical Industries & Medical Appliances's current Research & Development is ﷼59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saudi Pharmaceutical Industries & Medical Appliances stock overvalued right now?
Based on GuruFocus' analysis, Saudi Pharmaceutical Industries & Medical Appliances (SAU:2070) is currently considered Fairly Valued. The stock's GF Value™ is ﷼31.13, compared to a current price of ﷼28.26 — trading 9.2% below its estimated fair value. The current Research & Development is ﷼59 Mil. Saudi Pharmaceutical Industries & Medical Appliances' overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Saudi Pharmaceutical Industries & Medical Appliances (SAU:2070), the current Research & Development is ﷼59 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Saudi Pharmaceutical Industries & Medical Appliances (SAU:2070) Overvalued in 2026?

Based on GuruFocus' analysis, Saudi Pharmaceutical Industries & Medical Appliances stock appears to be undervalued. The current stock price of ﷼28.26 is trading 9.2% below its estimated GF Value™ of ﷼31.13. GuruFocus considers Saudi Pharmaceutical Industries & Medical Appliances to be Fairly Valued.

Key valuation signals for SAU:2070:

  • Research & Development: ﷼59 Mil
  • GF Value™: ﷼31.13 vs. price of ﷼28.26 (9.2% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the SAU:2070 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Saudi Pharmaceutical Industries & Medical Appliances Business Description

Address King Abdul Aziz Road, Industrial City of Al-Qassim, Buraidah, SAU
Saudi Pharmaceutical Industries & Medical Appliances Corp is involved in the manufacturing of basic chemical substances and products; medicines for human use, including cosmetics; pharmaceutical production and wholesale and retail of medicines and related products; development and marketing of medicinal and pharmaceutical products; research and development in medical science activities; operating and maintaining the healthcare facilities and any investments in related industries. The segments of the company are Pharmaceutical Manufacturing, Trading and Distribution services, and Healthcare Services, out of which the company derives maximum revenue from the Pharmaceutical Manufacturing segment. Its geographical segments are Saudi Arabia, Egypt, the Middle East, Morocco, and Algeria.
69GF Score

Get the complete analysis for SAU:2070

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼28.26
Price
﷼31.13
GF Value